Interim Results from the PRISM Randomized Phase 2 Dose Expansion Trial Evaluating 4D-150 in High Anti-Vegf Need Individuals with Neovascular (wet) Age-Related Macular Degeneration
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined